ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,532
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Effect of Nicotinic acid/Laropiprant on lipoprotein (a) in patients receiving LDL apheresis
Author(s):
Suzanne Watkins
,
Anne Govier
,
Hazel Weedon
,
Dev Datta
Publication date
Created:
October 2011
Publication date
(Print):
October 2011
Journal:
Atherosclerosis
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Functional role of amyloid
Author and article information
Journal
Title:
Atherosclerosis
Abbreviated Title:
Atherosclerosis
Publisher:
Elsevier BV
ISSN (Print):
00219150
Publication date Created:
October 2011
Publication date (Print):
October 2011
Volume
: 218
Issue
: 2
Pages
: e11-e12
Article
DOI:
10.1016/j.atherosclerosis.2011.07.090
SO-VID:
0d1fccf1-ea58-437d-a96c-1d081bfaf7e1
Copyright ©
© 2011
License:
http://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
4,532
Efficacy and safety profile of co-administered ER niacin/laropiprant and simvastatin in dyslipidaemia
Authors:
G Gleim
,
CM Ballantyne
,
N Liu
…
Efficacy and safety of extended-release niacin/laropiprant in patients with type 2 diabetes mellitus
Authors:
A. G. Maclean
,
JM McKenney
,
R Scott
The effects of laropiprant, a selective prostaglandin D(2) receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin
Authors:
A Dallob
,
WL Luo
,
JM Luk
See all similar